A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease

NCT00144781 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis I
Hurler's Syndrome
Hurler-Scheie Syndrome
Scheie Syndrome

Interventions

BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]